__timestamp | Eli Lilly and Company | Pfizer Inc. |
---|---|---|
Wednesday, January 1, 2014 | 4733600000 | 8393000000 |
Thursday, January 1, 2015 | 4796400000 | 7690000000 |
Friday, January 1, 2016 | 5243900000 | 7872000000 |
Sunday, January 1, 2017 | 5281800000 | 7657000000 |
Monday, January 1, 2018 | 5051200000 | 8006000000 |
Tuesday, January 1, 2019 | 5595000000 | 8650000000 |
Wednesday, January 1, 2020 | 6085700000 | 9405000000 |
Friday, January 1, 2021 | 7025900000 | 13829000000 |
Saturday, January 1, 2022 | 7190800000 | 11428000000 |
Sunday, January 1, 2023 | 9313400000 | 10679000000 |
Monday, January 1, 2024 | 14271000000 | 10930000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Eli Lilly and Pfizer have been at the forefront of research and development (R&D) spending. From 2014 to 2023, Pfizer consistently outpaced Eli Lilly in R&D investment, with an average annual expenditure of approximately $9.4 billion, compared to Eli Lilly's $6 billion. However, Eli Lilly has shown a remarkable growth trajectory, increasing its R&D spending by nearly 97% from 2014 to 2023. In 2023, Eli Lilly's R&D expenses surged to $9.3 billion, closing the gap with Pfizer, which spent $10.7 billion. This trend highlights Eli Lilly's aggressive push towards innovation, potentially reshaping the pharmaceutical landscape. As these giants continue to invest heavily in R&D, the future of medicine looks promising, with new breakthroughs on the horizon.
Analyzing R&D Budgets: Eli Lilly and Company vs Zoetis Inc.
Research and Development Investment: Eli Lilly and Company vs argenx SE
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and MiMedx Group, Inc.
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Grifols, S.A.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
Pfizer Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Pfizer Inc. and Novavax, Inc. Allocate Funds